List of works - Marc Hafner

'Glocal' robustness analysis and model discrimination for circadian oscillators

scientific article

A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro

scientific article published on 10 August 2015

A multi-center study on factors influencing the reproducibility of in vitro drug-response studies

A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers.

scientific article

Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics

scientific article published in June 2017

Analysis of growth factor signaling in genetically diverse breast cancer lines

scientific article

Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.

scientific article published on 30 October 2017

Deterministic characterization of phase noise in biomolecular oscillators.

scientific article published on 10 August 2011

Effect of network architecture on synchronization and entrainment properties of the circadian oscillations in the suprachiasmatic nucleus

scientific article

Efficient characterization of high-dimensional parameter spaces for systems biology.

scientific article

Explaining the length threshold of polyglutamine aggregation

scientific article published on 18 May 2012

Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients

scientific article published on 25 January 2021

Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold

scientific article published on 7 May 2015

Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs

scientific article

Growth‐rate model predicts in vivo tumor response from in vitro data

scientific article published in 2022

L1000CDS2: LINCS L1000 characteristic direction signatures search engine

scientific article

LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures

scientific article

Mapping behavioral specifications to model parameters in synthetic biology

scientific article

Modular design of artificial tissue homeostasis: robust control through synthetic cellular heterogeneity

scientific article

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity

scientific article published on 06 June 2019

PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis

scientific article published on 01 January 2022

Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines

scientific article

Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics

scientific article

List of works by Marc Hafner

'Glocal' robustness analysis and model discrimination for circadian oscillators

A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro

A multi-center study on factors influencing the reproducibility of in vitro drug-response studies

A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers.

Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics

Analysis of growth factor signaling in genetically diverse breast cancer lines

Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.

Deterministic characterization of phase noise in biomolecular oscillators.

Effect of network architecture on synchronization and entrainment properties of the circadian oscillations in the suprachiasmatic nucleus

Efficient characterization of high-dimensional parameter spaces for systems biology.

Explaining the length threshold of polyglutamine aggregation

Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients

Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold

Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs

Growth‐rate model predicts in vivo tumor response from in vitro data

L1000CDS2: LINCS L1000 characteristic direction signatures search engine

LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures

Mapping behavioral specifications to model parameters in synthetic biology

Modular design of artificial tissue homeostasis: robust control through synthetic cellular heterogeneity

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity

PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis

Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines

Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics